Get 50% OFF This Summer!

Advertisement
AdvertisementAdvertisement
logo

Aarti Pharmalabs

AARTIPHARM
Small Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Aarti Pharmalabs Share price and Fundamental Analysis

View All Details
View All Details
Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.
Company Incorporation2019
ChairmanRashesh C Gogri
Head QuartersMumbai
Previous NameNA

Key Metrics

Market Cap (Cr)
7,924.19
PE Ratio
29.09
Industry P/E
34.61
PEG Ratio
1.14
ROE
13.69%
ROCE
16.08%
ROA
9.37%
Total Debt (Cr)
411.48
Debt to Equity
0.21
Dividend Yield
0.29%
EPS
30.06
Book Value & P/B
203.44 x 4.3
Face Value
5
Outstanding Shares(Cr)
9.06
Current Ratio
3.68
EV to Sales
3.8

Included In

+More

Stock Returns

1 Week+7.91%
1 Month+22.92%
6 Months+33.93%
1 Year+44.16%
3 Years+203.59%
5 Years+203.59%

CAGR

1 Year CAGR

Revenue Growth

-4.76%

Net Profit Growth

+12.1%

Operating Profit Growth

+13.52%

Dividend Growth

+50%

Stock Returns CAGR

+44.16%
no_data

No Stocks

Smart Score

3.1
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Dec 24

Promoters : 44.66%

FIIs : 8.64%

DIIs : 10.36%

Public : 36.34%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in December 2024 Qtr
FII Shareholding Increased by 1.27% to 8.64% in December 2024 Qtr
Promoter Shareholding Decreased by 1.45% to 44.66% in December 2024 Qtr
DII Shareholding Decreased by 0.99% to 10.36% in December 2024 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Aarti Pharmalabs Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Aarti Pharmalabs Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.

In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.

The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.

Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.

9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.

Aarti Pharmalabs Share Price

Aarti Pharmalabs share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Aarti Pharmalabs Market Cap

Market capitalization of Aarti Pharmalabs indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Aarti Pharmalabs is valued compared to its competitors.

Aarti Pharmalabs PE Ratio

Aarti Pharmalabs PE ratio helps investors understand what is the market value of each stock compared to Aarti Pharmalabs 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Aarti Pharmalabs PEG Ratio

The PEG ratio of Aarti Pharmalabs evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Aarti Pharmalabs ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Aarti Pharmalabs generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Aarti Pharmalabs ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Aarti Pharmalabs in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Aarti Pharmalabs Total Debt

Total debt of Aarti Pharmalabs shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Aarti Pharmalabs Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Aarti Pharmalabs compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Aarti Pharmalabs CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Aarti Pharmalabs over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Aarti Pharmalabs Technical Analysis

Technical analysis of Aarti Pharmalabs helps investors get an insight into when they can enter or exit the stock. Key components of Aarti Pharmalabs Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Aarti Pharmalabs shares often struggle to rise above due to selling pressure.

Aarti Pharmalabs Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Aarti Pharmalabs ’s financial health and profitability.

Aarti Pharmalabs Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Aarti Pharmalabs Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Aarti Pharmalabs Financials

The financials of Aarti Pharmalabs provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Aarti Pharmalabs Profit and Loss Statements

The profit and loss statement of Aarti Pharmalabs highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Aarti Pharmalabs .

Aarti Pharmalabs Balance Sheet

The balance sheet presents a snapshot of Aarti Pharmalabs ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Aarti Pharmalabs Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App